Navigation Links
Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
Date:2/11/2010

CRANBURY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today additional positive preliminary data from its ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease at the Lysosomal Disease Network WORLD Symposium in Miami, Florida.  The Company also presented encouraging data from preclinical studies evaluating the combination of pharmacological chaperones and enzyme replacement therapy (ERT) for Fabry disease and Pompe disease as well as from preclinical studies examining the use of pharmacological chaperones for the treatment of Parkinson's disease.  

Phase 2 Extension Study Overview

Twenty-six subjects completed either 12 or 24 weeks of treatment with migalastat HCl during the initial Phase 2 studies and twenty-three subjects enrolled in a separate, voluntary long-term extension study designed to evaluate the long-term safety and efficacy of migalastat HCl.  Over the course of the initial Phase 2 and extension studies, fifteen subjects have been treated with migalastat HCl for approximately 2-3 years and eight subjects have been treated with migalastat HCl for more than 3 years.  Twenty-one subjects continue to receive treatment in the ongoing extension study.

Preliminary Data Update from Long-term Phase 2 Extension Study

During the course of the extension study, treatment with migalastat HCl has been generally well-tolerated, with no drug-related serious adverse events.  The most common adverse events were headache, arthralgia and diarrhea.  

Renal function is being evaluated by two measures in the extension study, estimated glomerular filtrat
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
2. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
3. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
4. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
5. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
6. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
7. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
8. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
9. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
10. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013  B. Braun Medical Inc. ... environmental safety with products, services and education focused ... its innovative Outlook® 400ES and Space Infusion Systems, ... at the American Association of Critical-Care Nurses (AACN) ... Boston Convention Center. ...
(Date:5/20/2013)... , May 20, 2013 Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... today that its Board of Directors declared, at its ... dividend of $0.55 per share for the third quarter ... July 3, 2013, to shareholders of record on June ...
(Date:5/20/2013)... , May 20, 2013  Uroplasty, Inc. (Nasdaq: ... financial results for the fiscal fourth quarter and full ... on Thursday, May 30, 2013. The Company will host ... on Thursday, May 30, 2013 at 4:30 p.m. Eastern ... in the conference call should dial 888-549-7750, no passcode ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Landauer, Inc. Declares Regular Cash Dividend 2Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2
... 2, 2011 The Long Term Care Pharmacy Alliance ... Centers for Medicare and Medicaid Services (CMS) regarding potential ... consideration of the Conditions of Participation for Long Term ... Our member companies and individual pharmacists have expressed sincere ...
... Nov. 2, 2011 LORENZ customers and business partners have ... Article 57(2) of Regulation (EC) 726/2004 and its impact on ... Interest Group for EVMPD – XEVPRM. One of ... registration are the Requirements of Article 57(2) of Regulation (EC) ...
Cached Medicine Technology:Proposed CMS Changes Related to Consultant Pharmacists Raise Profound Concerns for Pharmacies 2LORENZ' Response to New EU PV Legislation - Regulation No. 1235/2010 and EVMPD 2
(Date:5/20/2013)... May 20, 2013 According to a May ... at Indoor Tanning Salons,” tanning salons in the ... Food and Drug Administration wants to see cancer warnings on ... minimum age floor of eighteen for the use of indoor ... about melanoma, which has become increasingly common over the last ...
(Date:5/20/2013)... York, New York (PRWEB) May 20, 2013 ... to move forward in the multidistrict litigation recently established ... Bernstein Liebhard LLP reports. According to court records, ... 17th, at which time appointments to Plaintiff’s leadership positions ... lawsuits are pending in the Southern District of New ...
(Date:5/20/2013)... MI (PRWEB) May 20, 2013 ... Lupus Foundation will be holding ... in Lansing on June 10th. ... June 10th, 6:30 p.m. – ... Building (Across from Sparrow Hospital), ...
(Date:5/20/2013)... 2013 The Environmental Design ... dozens of continuing education credit opportunities for design ... of Architects Continuing Education System (AIA/CES), the Landscape ... Interior Design Continuing Education Council (IDCEC). EDRA44Providence ... 2013 at the Omni Providence Hotel in Providence, ...
(Date:5/20/2013)... According to a June 2009 Bloomberg article, ... amount to approximately $3.6 billion dollars per year (i). ... estimated that there 15 million incidents of medical harm ... everyone who receives any form of medical treatment should ... Merriam-Webster defines malpractice as “a dereliction of professional duty ...
Breaking Medicine News(10 mins):Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2
... Bluegrass Bariatric Surgical,Associates announced today that the final ... designed to evaluate the results of an,innovative Incisionless ... (Revision Obesity Surgery, Endolumenal). The ROSE procedure reduces,the ... and stoma to,approximate the original post-gastric bypass proportions ...
... to Provide Clinical Services Across the U.S., ... LMT ) announced today that the corporation received ... to $56.7 million to support Federal Occupational Health ... Martin will provide,medical and administrative staffing to perform ...
... Stanford University School of Medicine have discovered a promising ... Their discovery hinges on a novel "double agent" role ... The rogue signal, glycogen synthase kinase 3, was previously ... of cancer. It also keeps growth of healthy cells ...
... 100 student,government leaders, representing more than one million ... 5-7 to discuss,healthcare issues under the banner of ... Americans in the debate over healthcare., The ... blocks from,the Oct. 7 presidential debate between Barack ...
... Minnix, president and CEO of the American Association of ... members Jill Schumann,CEO of Lutheran Services in America (LSA) ... the NonProfit Times, "Power and Influence,Top 50" list., ... are selected for "the impact they have now and ...
... SAN DIEGO, Sept. 17 AMN Healthcare, the ... its international,division, O,Grady Peyton International (OGPI), today announced ... recruitment of foreign-educated,nurses to the United States., ... with unions, healthcare,organizations, educational and licensure bodies developed ...
Cached Medicine News:Health News:Final Patient Enrolled In Large Data Registry of Incisionless Gastric Pouch and Stoma Reduction Procedure 2Health News:Final Patient Enrolled In Large Data Registry of Incisionless Gastric Pouch and Stoma Reduction Procedure 3Health News:Final Patient Enrolled In Large Data Registry of Incisionless Gastric Pouch and Stoma Reduction Procedure 4Health News:Lockheed Martin Awarded Contract to Expand its Federal Occupational Healthcare Services 2Health News:New leukemia signal could point way to better treatment, Stanford researchers find 2Health News:College Students Seek Healthcare Solutions on Eve of Debate 2Health News:Three AAHSA Leaders Named to NonProfit Times' 'Power and Influence Top 50' List 2Health News:AMN Healthcare, OGPI Endorse AcademyHealth's Code of Conduct for Recruitment of Foreign-Educated Nurses 2Health News:AMN Healthcare, OGPI Endorse AcademyHealth's Code of Conduct for Recruitment of Foreign-Educated Nurses 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: